CombiChem, Teijin Ltd. deal

The companies will collaborate to discover antagonists of a specific G-protein coupled receptor target using CombiChem's combinatorial chemistry and molecular discovery technologies. CombiChem will design and synthesize compound libraries based around a lead molecule selected by Teijin. Teijin will perform screening and biological support. ...